Legal & General Group Plc - CASI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$17,000
-29.2%
6,908
-14.3%
0.00%
Q4 2020$24,000
+100.0%
8,0620.0%0.00%
Q3 2020$12,000
-42.9%
8,062
-5.5%
0.00%
Q2 2020$21,000
+23.5%
8,528
+0.4%
0.00%
Q1 2020$17,000
-51.4%
8,493
-24.0%
0.00%
Q4 2019$35,000
+40.0%
11,180
+50.2%
0.00%
Q3 2019$25,000
+4.2%
7,4420.0%0.00%
Q2 2019$24,000
+14.3%
7,4420.0%0.00%
Q1 2019$21,000
-30.0%
7,4420.0%0.00%
Q4 2018$30,000
-14.3%
7,4420.0%0.00%
Q3 2018$35,000
-42.6%
7,4420.0%0.00%
Q2 2018$61,0007,4420.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders